Article Text
Letter
Patient organisation-led initiatives can play an important role in raising awareness about Raynaud’s phenomenon and encourage earlier healthcare utilisation for high-risk groups
Statistics from Altmetric.com
Footnotes
Handling editor Josef S Smolen
Contributors All authors were involved in the planning, conduct and reporting of the work described in the article.
Funding This study was funded by Scleroderma and Raynaud’s UK.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.